Q2M Biotech AG (HAM:QBI) Change In Receivables : €0.00 Mil (TTM As of . 20)

View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Change In Receivables?

Q2M Biotech AG's change in receivables for the quarter that ended in . 20 was €0.00 Mil. It means Q2M Biotech AG's Accounts Receivable stayed the same from . 20 to . 20 .

Q2M Biotech AG's change in receivables for the fiscal year that ended in . 20 was €0.00 Mil. It means Q2M Biotech AG's Accounts Receivable stayed the same from . 20 to . 20 .

Q2M Biotech AG's Accounts Receivable for the quarter that ended in . 20 was €0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Q2M Biotech AG's liquidation value for the three months ended in . 20 was €0.00 Mil.

Q2M Biotech AG Change In Receivables Historical Data

The historical data trend for Q2M Biotech AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Change In Receivables Chart

Q2M Biotech AG Annual Data

Trend

Change In Receivables

Q2M Biotech AG Quarterly Data

Change In Receivables

Q2M Biotech AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Q2M Biotech AG (HAM:QBI) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Q2M Biotech AG's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=		/		*	91
=

2. In Ben Graham's calculation of liquidation value, Q2M Biotech AG's accounts receivable are only considered to be worth 75% of book value:

Q2M Biotech AG's liquidation value for the quarter that ended in . 20 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=		-		+	0.75 *	+	0.5 *
=	0.00

Q2M Biotech AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Q2M Biotech AG (HAM:QBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Haeschenstrasse 17-19, Bremen, DEU

Website

http://

Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines